State Medicaid committees quietly shape drug access for over 90
million Americans. Preferred drug lists shift. Prior authorizations
appear. Coverage criteria change — often with little notice and less
transparency.

Concis·Labs was built to fix that blind spot.

We have eyes and ears in every P&T, DUR, PDAC, and RDAC committee
across the country. We capture the discussions, extract the signals,
and deliver actionable intelligence directly to pharma market access
teams — in real time, not weeks later.

Our clients don't just track formulary changes. They anticipate them.
When Florida adds a prior authorization to a drug class, they already
know which ten states are likely to follow.

Searchable meeting archives. Real-time alerts. Competitive
intelligence that compounds over time.

Built for pharma and biotech VPs, executive directors, and market
access leaders who need to move faster than the regulatory landscape.

concislabs.com

Concis Labs

Org chart

Teams

Offices